HALEOSLABS

Haleos Labs Share Price

 

 

Start SIP in HALEOSLABS

Start SIP

Performance

  • Low
  • ₹1,306
  • High
  • ₹1,370
  • 52 Week Low
  • ₹960
  • 52 Week High
  • ₹1,680
  • Open Price₹1,357
  • Previous Close₹1,357
  • Volume599

Investment Returns

  • Over 1 Month + 11.36%
  • Over 3 Month + 17.7%
  • Over 6 Month + 0.4%
  • Over 1 Year + 12.79%

Smart Investing Starts Here Start SIP with Haleos Labs for Steady Growth!

Invest Now

Haleos Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.3
  • PEG Ratio
  • -1.5
  • Market Cap Cr
  • 398
  • P/B Ratio
  • Average True Range
  • 70.72
  • EPS
  • 61.85
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 50.48
  • RSI
  • 52.5
  • MFI
  • 58.64

Haleos Labs Financials

Haleos Labs Technicals

EMA & SMA

Current Price
₹1,315.10
-41.4 (-3.05%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹1,318.32
  • 50 Day
  • ₹1,252.82
  • 100 Day
  • ₹1,221.74
  • 200 Day
  • ₹1,200.25

Resistance and Support

1330.37 Pivot Speed
  • R3 1,418.73
  • R2 1,394.37
  • R1 1,354.73
  • S1 1,290.73
  • S2 1,266.37
  • S3 1,226.73

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Haleos Labs Ltd has an operating revenue of Rs. 337.59 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 8% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 12% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 66 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Haleos Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-10 Quarterly Results
2025-08-11 Quarterly Results & A.G.M.
2025-05-29 Audited Results & Dividend
2025-02-12 Quarterly Results & Others To consider other business matters. per share(15%)Dividend
2024-11-13 Quarterly Results
Date Purpose Remarks
2025-09-24 FINAL Rs.1.50 per share(15%)Dividend
View Haleos Labs Dividend History Arrow

Haleos Labs F&O

Haleos Labs Shareholding Pattern

71.41%
0%
25.32%
3.27%

About Haleos Labs

  • NSE Symbol
  • HALEOSLABS
  • BSE Symbol
  • 540679
  • Managing Director
  • Mr. TVVSN Murthy
  • ISIN
  • INE320X01016

Similar Stocks to Haleos Labs

Haleos Labs FAQs

Haleos Labs share price is ₹1,315 As on 05 December, 2025 | 08:31

The Market Cap of Haleos Labs is ₹397.6 Cr As on 05 December, 2025 | 08:31

The P/E ratio of Haleos Labs is 21.3 As on 05 December, 2025 | 08:31

The PB ratio of Haleos Labs is 2.1 As on 05 December, 2025 | 08:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23